Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Unknown 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3

Conditions

Multiple Myeloma 449Neoplasms, Plasma Cell 69Recurrence 42Immunoglobulin Light-chain Amyloidosis 24Neoplasms 12Paraproteinemias 9Lymphoma, Non-Hodgkin 9Leukemia, Lymphocytic, Chronic, B-Cell 9Hematologic Neoplasms 9Renal Insufficiency 8Amyloidosis 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Mantle-Cell 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Lymphoma 7Lymphoma, B-Cell, Marginal Zone 6Leukemia, Plasma Cell 6Leukemia, Myeloid, Acute 6Hematologic Diseases 6Waldenstrom Macroglobulinemia 5Lymphoma, Large-Cell, Immunoblastic 5Leukemia 5Burkitt Lymphoma 5Immunoproliferative Disorders 4Hodgkin Disease 4Blood Protein Disorders 4Plasmacytoma 3Peripheral Nervous System Diseases 3Neoplasms by Histologic Type 3

Interventions

Dexamethasone 3Bortezomib 3Acupuncture Therapy 3Tablets 1Lenalidomide 1Glutamine 1G(M1) Ganglioside 1Fenofibrate 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Peripheral Nervous System Diseases × Bortezomib × Plasma cell × Clear all
NCT07025005 2025-11-04

VRd MM Fibrate

Tanta University

Phase 4 Recruiting
44 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Peripheral Nervous System Diseases

NCT02362165 2016-04-20

CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma

Sun Yat-sen University

Phase 3 Unknown
236 enrolled
Plasma cell

Multiple Myeloma, Peripheral Nervous System Diseases

NCT02093910 2014-11-19

Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy

Sun Yat-sen University

Phase 2 Unknown
100 enrolled
Plasma cell

Multiple Myeloma, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡